.Nature Medication, Posted online: 16 September 2024 doi:10.1038/ s41591-024-03244-8In the observational SCRUM-Japan GOZILA research study, after a typical consequence of 11 months, clients with metastatic stomach cysts who obtained biomarker-matched therapies based upon distributing growth DNA profiling presented a higher clinical perk than those getting unrivaled treatment.